Gene-Guided chemo trial aims to improve survival in tough breast cancer
Disease control
Recruiting now
This phase 2 trial is testing whether using gene tests (MammoPrint and BluePrint) to guide treatment can help people with a certain type of advanced breast cancer (HR+, HER2-negative) live longer. 64 participants will receive either chemotherapy (capecitabine) or hormone therapy …
Phase: PHASE2 • Sponsor: Sonya Reid • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC